Astellas Pharma Ltd

3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Patient Information Leaflet last updated on the eMC: 23/12/2009
PIL Flomaxtra XL

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/12/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to side-effects
Updated on 04/03/2009 and displayed until 23/12/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 07/11/2006 and displayed until 04/03/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 17/08/2006 and displayed until 07/11/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   tamsulosin hydrochloride